(Bloomberg) -- The structural concerns that led New York City officials to shut down a Midtown Manhattan high-rise and ...

The tables have turned for the U.S. biosimilars market. With more than a decade since the first FDA biosim approval, strong launches to biologic copies to AbbVie’s Humira, J&J’s Stelara and ...

Albert Bourla, Pfizer Chairman & CEO, discusses strong performance in primary care and the game-changing Metsera acquisition ...

Pfizer CEO Albert Bourla details $70B US investment in manufacturing and R&D, discussing oncology advancements, the GLP-1 drug race, and AI's transformative role in drug development on 'Mornings with ...

Brian Evanko, Cigna Group’s new chief executive officer, said he aims to put patients at the center of the company’s strategy ...

Biotech investors, executives and analysts worry that blanket bans on deals with Chinese companies could curb domestic ...

Thursday's ruling by the U.S. Supreme Court could wipe out tens of thousands of Roundup lawsuits, but some plaintiffs' ...

WALL STREET, New York - June 10, 2014 - The Wall Street Transcript has just published its Investing Strategies Report. This special feature contains expert industry commentary through in-depth ...

In the latest China pharmaceutical industry collaboration pact with a global drug leader, Abbisko said today it will work ...

The sports apparel giant is turning to new financial leadership as it looks to make more progress with its “Win Now” ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...